Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001651431-20-000004
Filing Date
2020-06-18
Accepted
2020-06-18 16:38:40
Documents
1
Effectiveness Date
2020-06-18
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 15126
  Complete submission text file 0001651431-20-000004.txt   16256
Mailing Address 245 MAIN STREET, 2ND FLOOR CAMBRIDGE MA 02142
Business Address 245 MAIN STREET, 2ND FLOOR CAMBRIDGE MA 02142 978-503-2124
Checkmate Pharmaceuticals, Inc. (Filer) CIK: 0001651431 (see all company filings)

EIN.: 364813934 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-369265 | Film No.: 20973128
SIC: 2836 Biological Products, (No Diagnostic Substances)